The weight loss jab Wegovy is being made available in the UK as part of a “controlled and limited launch”. The drug, also known as semaglutide, will be prescribed via specialist NHS weight management services alongside a reduced calorie diet and exercise from today (Monday September 4).
Those eligible should have a body mass index (BMI) over 30 or a BMI of more than 27 and at least one weight-related co-morbidity.
The National Institute for Care and Excellence (Nice) gave Wegovy the green light for NHS use earlier this year. Its guidance said it should be used for a “maximum” of two years. Try MEN Premium for FREE by clicking here for no ads, fun puzzles and brilliant new features. Wegovy manufacturer Novo Nordisk said it believes the launch of the drug in the UK “will help provide an additional option to support people living with obesity”.
In June, the Government announced a £40 million pilot to expand access to weight-loss jabs is to tackle obesity. Speaking at the time, Prime Minister Rishi Sunak said the drug could be a “game-changer”.
Read more on manchestereveningnews.co.uk